The porcine vaccine market has grown from $1.74 billion in 2023 to $1.91 billion in 2024, reflecting a CAGR of 9.5%. Factors such as disease control measures, increased pork consumption, and pig farming intensification have driven this growth. The market is projected to reach $2.73 billion by 2028, with a CAGR of 9.4%. Key trends include customized vaccines, biotechnology integration, and increased research and development investments.
Major Driver In The Porcine Vaccine Market
The increasing infection of swine disease will propel the growth of the porcine vaccine market going forward. Swine influenza (swine flu) commonly affects pigs, caused by the type A influenza virus, often leading to influenza outbreaks. Porcine vaccines are administered to pigs, triggering their immune systems to respond to the vaccine and recognize the pathogenic agent, thus inducing an immunogenic reaction. These vaccines prepare the swine’s immune system to combat pathogens, preventing sickness by triggering an anamnestic reaction upon encountering the same pathogen. For example, in December 2021, European countries reported 1,844 outbreaks of African Swine Fever (ASF) in domestic pigs, as per the report by the Swine Health Information Centre. Consequently, the rising infection of swine disease is driving the porcine vaccine market. Market projections for 2023 emphasize significant growth potential in the porcine vaccine sector, driven by the escalating incidence of swine diseases. Forecasts for 2024 and beyond anticipate sustained market expansion, fueled by the increasing need for effective vaccination strategies in the swine industry.
Request A Free Sample Of The Global Porcine Vaccine Market Report
Porcine Vaccine Market Competitive Landscape
Bayer AG, Sanofi Pasteur Inc., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Zoetis Inc., Arko Laboratories Limited, Merck Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., Ringpu Bio-Pharmacy Co Ltd., IDT Biologika GmbH, Bimeda Holdings PLC, Jinyu Bio-Technology Co Ltd., Biogénesis Bagó, ProBioGen AG, Pharmaq AS, Veterquimica S.A., Kyoto Biken Laboratories Inc., Dopharma Research B.V., Agrovet Market Animal Health Ltd., Innovad SA, PBS Animal Health, Merial Animal Health, Biozoo S.A., Aptimmune Biologics Inc., Syntex SA de CV, Zoovet S.A., Shenzhen Weierkang Xiang Animal Pharm Co Ltd., Wuhan Keqian Biology Co Ltd., Anicon Labor GmbH
Key Porcine Vaccine Market Trend
Major companies operating in the porcine vaccine market are focused on developing innovative products, such as a new swine vaccine, to protect pigs from various syndromes. Swine vaccines are a crucial component of swine health management, aimed at protecting pigs from various diseases. For instance, in September 2021, Boehringer Ingelheim, a Germany-based vaccine manufacturing company, launched FLEX ParvoPRRS, the first vaccine to combine the efficacy and safety of industry-leading Reprocyc ParvoFLEX for PPV and Ingelvac PRRSFLEX MLV for PRRS. This vaccine is designed to protect pigs from Porcine Reproductive and Respiratory Syndrome (PRRS) and Porcine Parvovirus, two significant threats to swine health. It promises better breeding herds and larger litters by enhancing reproductive health and productivity. The new combination vaccine is safe for all stages of breastfeeding and gestation and supports mass vaccination strategies in breeding herds.
Get The Full Global Porcine Vaccine Market Report
Porcine Vaccine Market Segmentation
The porcine vaccines market covered in this report is segmented –
1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines
2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordatella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications
3) By End User: Veterinary Hospitals, Hog or Pig Production Farm
By Geography:The regions covered in the porcine vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America is the largest region in the porcine vaccine market in 2023.
The Porcine Vaccine Global Market Report 2024 furnishes information about the global porcine vaccine market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.
